Loading…
Metabolic and ultrastructural effects of cyclosporin A on pancreatic islets
We investigated the effect of different doses of cyclosporin A (CyA) on glucose and insulin levels, as well as its residual effects on pancreatic islets ultrastructure after discontinuation of the drug. We studied four groups of Wistar rats. One control- (n = 5) and three experimental groups, n = 10...
Saved in:
Published in: | Transplant international 1999-05, Vol.12 (3), p.208-212 |
---|---|
Main Authors: | , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c280t-6a85eea112a8563642993650fbaa1d976d53aa6c327aefe17cf7701cffbfa8a93 |
---|---|
cites | |
container_end_page | 212 |
container_issue | 3 |
container_start_page | 208 |
container_title | Transplant international |
container_volume | 12 |
creator | BAKONYI NETO, A HAAPALAINEN, E NIGRO, A. T FERREIRA, R FEO, C. F MISIAKO, E. P VENNARECCI, G PORCU, A DIB, S. A GOLDENBERG, S GOMES, P. O |
description | We investigated the effect of different doses of cyclosporin A (CyA) on glucose and insulin levels, as well as its residual effects on pancreatic islets ultrastructure after discontinuation of the drug. We studied four groups of Wistar rats. One control- (n = 5) and three experimental groups, n = 10 each, were treated with different doses of CyA i.m. for 14 days: group I, 5 mg/Kg; group II, 15 mg/Kg; and group III, 25 mg/Kg. Five animals of each group were sacrificed after 14 days, and the remaining five after 21 days to assess residual CyA effects. On the day of sacrifice, the rats underwent maltose absorption test, and glucose and insulin levels were measured. Pancreatic biopsies were obtained on day 21 to evaluate islets ultrastructure by electron microscopy. As a result, statistically significant, dose dependent (P < 0.05) increases in glucose and insulin levels were observed in CyA-treated groups. Groups II and III showed insulin levels significantly higher after fasting (P < 0.05) on day 14 comparing to the controls, while in groups I and II values returned to normal after CyA discontinuation. Group III showed persistently increased insulin levels on day 21. Pancreatic ultrastructural changes were observed only in group III. We can conclude that CyA effects on glucose and insulin levels were temporary and reversible at low doses. Ultrastructural changes in the pancreatic islets may occur with high doses of CyA. |
doi_str_mv | 10.1007/s001470050212 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_69925954</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69925954</sourcerecordid><originalsourceid>FETCH-LOGICAL-c280t-6a85eea112a8563642993650fbaa1d976d53aa6c327aefe17cf7701cffbfa8a93</originalsourceid><addsrcrecordid>eNpFzz1PwzAQBmALgWgpjKzIA2ILnL_ieKwqvkQRC8zRxbGlIDcJtjP03xNEEdPd8Lynewm5ZHDLAPRdAmBSAyjgjB-RJZOCF5xrfUyWYIQsoNJyQc5S-gQAXik4JQsGkhujzJK8vLqMzRA6S7Fv6RRyxJTjZPMUMVDnvbM50cFTu7dhSOMQu56u6dDTEXsbHeY52qXgcjonJx5DcheHuSIfD_fvm6di-_b4vFlvC8sryEWJlXIOGePzUory5xVRKvANImuNLlslEEsruEbnHdPWaw3Met94rNCIFbn5vTvG4WtyKde7LlkXAvZumFJdGsOVUXKGVwc4NTvX1mPsdhj39V_9GVwfACaLwce5Upf-XaW5FFJ8AxJoaXk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69925954</pqid></control><display><type>article</type><title>Metabolic and ultrastructural effects of cyclosporin A on pancreatic islets</title><source>Alma/SFX Local Collection</source><creator>BAKONYI NETO, A ; HAAPALAINEN, E ; NIGRO, A. T ; FERREIRA, R ; FEO, C. F ; MISIAKO, E. P ; VENNARECCI, G ; PORCU, A ; DIB, S. A ; GOLDENBERG, S ; GOMES, P. O</creator><creatorcontrib>BAKONYI NETO, A ; HAAPALAINEN, E ; NIGRO, A. T ; FERREIRA, R ; FEO, C. F ; MISIAKO, E. P ; VENNARECCI, G ; PORCU, A ; DIB, S. A ; GOLDENBERG, S ; GOMES, P. O</creatorcontrib><description>We investigated the effect of different doses of cyclosporin A (CyA) on glucose and insulin levels, as well as its residual effects on pancreatic islets ultrastructure after discontinuation of the drug. We studied four groups of Wistar rats. One control- (n = 5) and three experimental groups, n = 10 each, were treated with different doses of CyA i.m. for 14 days: group I, 5 mg/Kg; group II, 15 mg/Kg; and group III, 25 mg/Kg. Five animals of each group were sacrificed after 14 days, and the remaining five after 21 days to assess residual CyA effects. On the day of sacrifice, the rats underwent maltose absorption test, and glucose and insulin levels were measured. Pancreatic biopsies were obtained on day 21 to evaluate islets ultrastructure by electron microscopy. As a result, statistically significant, dose dependent (P < 0.05) increases in glucose and insulin levels were observed in CyA-treated groups. Groups II and III showed insulin levels significantly higher after fasting (P < 0.05) on day 14 comparing to the controls, while in groups I and II values returned to normal after CyA discontinuation. Group III showed persistently increased insulin levels on day 21. Pancreatic ultrastructural changes were observed only in group III. We can conclude that CyA effects on glucose and insulin levels were temporary and reversible at low doses. Ultrastructural changes in the pancreatic islets may occur with high doses of CyA.</description><identifier>ISSN: 0934-0874</identifier><identifier>EISSN: 1432-2277</identifier><identifier>DOI: 10.1007/s001470050212</identifier><identifier>PMID: 10429959</identifier><language>eng</language><publisher>Oxford: Blackwell Publishing</publisher><subject>Animals ; Biological and medical sciences ; Cyclosporine - administration & dosage ; Cyclosporine - pharmacology ; Dose-Response Relationship, Drug ; Drug toxicity and drugs side effects treatment ; Glucose - metabolism ; Immunosuppressive Agents - administration & dosage ; Immunosuppressive Agents - pharmacology ; Insulin - metabolism ; Islets of Langerhans - drug effects ; Islets of Langerhans - metabolism ; Islets of Langerhans - ultrastructure ; Medical sciences ; Microscopy, Electron ; Miscellaneous (drug allergy, mutagens, teratogens...) ; Pharmacology. Drug treatments ; Rats ; Rats, Wistar</subject><ispartof>Transplant international, 1999-05, Vol.12 (3), p.208-212</ispartof><rights>1999 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c280t-6a85eea112a8563642993650fbaa1d976d53aa6c327aefe17cf7701cffbfa8a93</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1872434$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10429959$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>BAKONYI NETO, A</creatorcontrib><creatorcontrib>HAAPALAINEN, E</creatorcontrib><creatorcontrib>NIGRO, A. T</creatorcontrib><creatorcontrib>FERREIRA, R</creatorcontrib><creatorcontrib>FEO, C. F</creatorcontrib><creatorcontrib>MISIAKO, E. P</creatorcontrib><creatorcontrib>VENNARECCI, G</creatorcontrib><creatorcontrib>PORCU, A</creatorcontrib><creatorcontrib>DIB, S. A</creatorcontrib><creatorcontrib>GOLDENBERG, S</creatorcontrib><creatorcontrib>GOMES, P. O</creatorcontrib><title>Metabolic and ultrastructural effects of cyclosporin A on pancreatic islets</title><title>Transplant international</title><addtitle>Transpl Int</addtitle><description>We investigated the effect of different doses of cyclosporin A (CyA) on glucose and insulin levels, as well as its residual effects on pancreatic islets ultrastructure after discontinuation of the drug. We studied four groups of Wistar rats. One control- (n = 5) and three experimental groups, n = 10 each, were treated with different doses of CyA i.m. for 14 days: group I, 5 mg/Kg; group II, 15 mg/Kg; and group III, 25 mg/Kg. Five animals of each group were sacrificed after 14 days, and the remaining five after 21 days to assess residual CyA effects. On the day of sacrifice, the rats underwent maltose absorption test, and glucose and insulin levels were measured. Pancreatic biopsies were obtained on day 21 to evaluate islets ultrastructure by electron microscopy. As a result, statistically significant, dose dependent (P < 0.05) increases in glucose and insulin levels were observed in CyA-treated groups. Groups II and III showed insulin levels significantly higher after fasting (P < 0.05) on day 14 comparing to the controls, while in groups I and II values returned to normal after CyA discontinuation. Group III showed persistently increased insulin levels on day 21. Pancreatic ultrastructural changes were observed only in group III. We can conclude that CyA effects on glucose and insulin levels were temporary and reversible at low doses. Ultrastructural changes in the pancreatic islets may occur with high doses of CyA.</description><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Cyclosporine - administration & dosage</subject><subject>Cyclosporine - pharmacology</subject><subject>Dose-Response Relationship, Drug</subject><subject>Drug toxicity and drugs side effects treatment</subject><subject>Glucose - metabolism</subject><subject>Immunosuppressive Agents - administration & dosage</subject><subject>Immunosuppressive Agents - pharmacology</subject><subject>Insulin - metabolism</subject><subject>Islets of Langerhans - drug effects</subject><subject>Islets of Langerhans - metabolism</subject><subject>Islets of Langerhans - ultrastructure</subject><subject>Medical sciences</subject><subject>Microscopy, Electron</subject><subject>Miscellaneous (drug allergy, mutagens, teratogens...)</subject><subject>Pharmacology. Drug treatments</subject><subject>Rats</subject><subject>Rats, Wistar</subject><issn>0934-0874</issn><issn>1432-2277</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><recordid>eNpFzz1PwzAQBmALgWgpjKzIA2ILnL_ieKwqvkQRC8zRxbGlIDcJtjP03xNEEdPd8Lynewm5ZHDLAPRdAmBSAyjgjB-RJZOCF5xrfUyWYIQsoNJyQc5S-gQAXik4JQsGkhujzJK8vLqMzRA6S7Fv6RRyxJTjZPMUMVDnvbM50cFTu7dhSOMQu56u6dDTEXsbHeY52qXgcjonJx5DcheHuSIfD_fvm6di-_b4vFlvC8sryEWJlXIOGePzUory5xVRKvANImuNLlslEEsruEbnHdPWaw3Met94rNCIFbn5vTvG4WtyKde7LlkXAvZumFJdGsOVUXKGVwc4NTvX1mPsdhj39V_9GVwfACaLwce5Upf-XaW5FFJ8AxJoaXk</recordid><startdate>19990501</startdate><enddate>19990501</enddate><creator>BAKONYI NETO, A</creator><creator>HAAPALAINEN, E</creator><creator>NIGRO, A. T</creator><creator>FERREIRA, R</creator><creator>FEO, C. F</creator><creator>MISIAKO, E. P</creator><creator>VENNARECCI, G</creator><creator>PORCU, A</creator><creator>DIB, S. A</creator><creator>GOLDENBERG, S</creator><creator>GOMES, P. O</creator><general>Blackwell Publishing</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>19990501</creationdate><title>Metabolic and ultrastructural effects of cyclosporin A on pancreatic islets</title><author>BAKONYI NETO, A ; HAAPALAINEN, E ; NIGRO, A. T ; FERREIRA, R ; FEO, C. F ; MISIAKO, E. P ; VENNARECCI, G ; PORCU, A ; DIB, S. A ; GOLDENBERG, S ; GOMES, P. O</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c280t-6a85eea112a8563642993650fbaa1d976d53aa6c327aefe17cf7701cffbfa8a93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Cyclosporine - administration & dosage</topic><topic>Cyclosporine - pharmacology</topic><topic>Dose-Response Relationship, Drug</topic><topic>Drug toxicity and drugs side effects treatment</topic><topic>Glucose - metabolism</topic><topic>Immunosuppressive Agents - administration & dosage</topic><topic>Immunosuppressive Agents - pharmacology</topic><topic>Insulin - metabolism</topic><topic>Islets of Langerhans - drug effects</topic><topic>Islets of Langerhans - metabolism</topic><topic>Islets of Langerhans - ultrastructure</topic><topic>Medical sciences</topic><topic>Microscopy, Electron</topic><topic>Miscellaneous (drug allergy, mutagens, teratogens...)</topic><topic>Pharmacology. Drug treatments</topic><topic>Rats</topic><topic>Rats, Wistar</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>BAKONYI NETO, A</creatorcontrib><creatorcontrib>HAAPALAINEN, E</creatorcontrib><creatorcontrib>NIGRO, A. T</creatorcontrib><creatorcontrib>FERREIRA, R</creatorcontrib><creatorcontrib>FEO, C. F</creatorcontrib><creatorcontrib>MISIAKO, E. P</creatorcontrib><creatorcontrib>VENNARECCI, G</creatorcontrib><creatorcontrib>PORCU, A</creatorcontrib><creatorcontrib>DIB, S. A</creatorcontrib><creatorcontrib>GOLDENBERG, S</creatorcontrib><creatorcontrib>GOMES, P. O</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Transplant international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>BAKONYI NETO, A</au><au>HAAPALAINEN, E</au><au>NIGRO, A. T</au><au>FERREIRA, R</au><au>FEO, C. F</au><au>MISIAKO, E. P</au><au>VENNARECCI, G</au><au>PORCU, A</au><au>DIB, S. A</au><au>GOLDENBERG, S</au><au>GOMES, P. O</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Metabolic and ultrastructural effects of cyclosporin A on pancreatic islets</atitle><jtitle>Transplant international</jtitle><addtitle>Transpl Int</addtitle><date>1999-05-01</date><risdate>1999</risdate><volume>12</volume><issue>3</issue><spage>208</spage><epage>212</epage><pages>208-212</pages><issn>0934-0874</issn><eissn>1432-2277</eissn><abstract>We investigated the effect of different doses of cyclosporin A (CyA) on glucose and insulin levels, as well as its residual effects on pancreatic islets ultrastructure after discontinuation of the drug. We studied four groups of Wistar rats. One control- (n = 5) and three experimental groups, n = 10 each, were treated with different doses of CyA i.m. for 14 days: group I, 5 mg/Kg; group II, 15 mg/Kg; and group III, 25 mg/Kg. Five animals of each group were sacrificed after 14 days, and the remaining five after 21 days to assess residual CyA effects. On the day of sacrifice, the rats underwent maltose absorption test, and glucose and insulin levels were measured. Pancreatic biopsies were obtained on day 21 to evaluate islets ultrastructure by electron microscopy. As a result, statistically significant, dose dependent (P < 0.05) increases in glucose and insulin levels were observed in CyA-treated groups. Groups II and III showed insulin levels significantly higher after fasting (P < 0.05) on day 14 comparing to the controls, while in groups I and II values returned to normal after CyA discontinuation. Group III showed persistently increased insulin levels on day 21. Pancreatic ultrastructural changes were observed only in group III. We can conclude that CyA effects on glucose and insulin levels were temporary and reversible at low doses. Ultrastructural changes in the pancreatic islets may occur with high doses of CyA.</abstract><cop>Oxford</cop><pub>Blackwell Publishing</pub><pmid>10429959</pmid><doi>10.1007/s001470050212</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0934-0874 |
ispartof | Transplant international, 1999-05, Vol.12 (3), p.208-212 |
issn | 0934-0874 1432-2277 |
language | eng |
recordid | cdi_proquest_miscellaneous_69925954 |
source | Alma/SFX Local Collection |
subjects | Animals Biological and medical sciences Cyclosporine - administration & dosage Cyclosporine - pharmacology Dose-Response Relationship, Drug Drug toxicity and drugs side effects treatment Glucose - metabolism Immunosuppressive Agents - administration & dosage Immunosuppressive Agents - pharmacology Insulin - metabolism Islets of Langerhans - drug effects Islets of Langerhans - metabolism Islets of Langerhans - ultrastructure Medical sciences Microscopy, Electron Miscellaneous (drug allergy, mutagens, teratogens...) Pharmacology. Drug treatments Rats Rats, Wistar |
title | Metabolic and ultrastructural effects of cyclosporin A on pancreatic islets |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T14%3A07%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Metabolic%20and%20ultrastructural%20effects%20of%20cyclosporin%20A%20on%20pancreatic%20islets&rft.jtitle=Transplant%20international&rft.au=BAKONYI%20NETO,%20A&rft.date=1999-05-01&rft.volume=12&rft.issue=3&rft.spage=208&rft.epage=212&rft.pages=208-212&rft.issn=0934-0874&rft.eissn=1432-2277&rft_id=info:doi/10.1007/s001470050212&rft_dat=%3Cproquest_pubme%3E69925954%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c280t-6a85eea112a8563642993650fbaa1d976d53aa6c327aefe17cf7701cffbfa8a93%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=69925954&rft_id=info:pmid/10429959&rfr_iscdi=true |